Advancing Access to HIV/HCV Testing for People Who Inject Drugs (PWID)

Recruiting now · Not applicable

Conditions studied: HIV Infections

In brief

The purpose of this study is to test the effectiveness of the ACCESS strategy: an organizational-level intervention that uses funding and practice facilitation to improve the organizational capacity of syringe services programs (SSPs) to implement routine, opt-out HIV and Hepatitis C (HCV) testing and linkage to care for people who inject drugs (PWID).

Key facts

Study ID

NCT06730555

Run by

University of Miami

People needed

40

Starts

2025-06-27

Expected to finish

2028-08-01

Last updated by the study team

2026-02-03

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• SSPs must:
• be operating in an Ending the HIV Epidemic (EHE) or Centers for Disease Control and Prevention (CDC) determined vulnerable jurisdictions;
• serve at least 300 unique participants per year;
• not currently offer opt-out HIV/HCV testing;
• be capable and willing to prospectively collect aggregated, site-level data on the number of participants who are: i) offered HIV/HCV screening, ii) completed these tests, and iii) linked to care, as well as provide participant demographics;
• have key staff that consent to participate in study surveys, qualitative interviews and practice facilitation throughout the study.

You may not qualify if…

• SSPs must not:
• currently receive or have received Frontline Communities in the United States (FOCUS) funding;
• have already implemented opt-out HIV/HCV testing.
• currently participating in SAIA-SSP-HIV (NCT06025435)

Where it is running

• University of Miami — Miami, Florida, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.